# US 2021/0175443 A1 · Organic electroluminescent materials and devices

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0175443 A1
- Document ID: US20210175443A1
- Status: Published application
- Kind: A1
- Application number: 16/952,352
- Filed: 2020-11-19
- Published: 2021-06-10
- Earliest claimed: 2019-12-09
- Assignees: Universal Display Corporation
- Applicants: Universal Display Corporation
- Inventors: Nicholas J. THOMPSON; Hsiao-Fan CHEN; Sean Michael RYNO; Ivan MILAS
- Web page: https://patentgrep.com/patent/US20210175443A1

## CPC

- H10K 85/346: {comprising platinum}
- C07F 15/0086: {Platinum compounds}
- C09K 11/02: Use of particular materials as binders, particle coatings or suspension media therefor
- C09K 11/06: containing organic luminescent materials
- C09K 2211/1007: Non-condensed systems
- C09K 2211/1014: bridged by heteroatoms, e.g. N, P, Si or B
- C09K 2211/1022: bridged by heteroatoms, e.g. N, P, Si or B
- C09K 2211/1029: containing one nitrogen atom as the heteroatom
- C09K 2211/1044: containing two nitrogen atoms as heteroatoms
- C09K 2211/185: of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd
- H10K 50/11: characterised by the electroluminescent [EL] layers
- H10K 2101/10: Triplet emission
- H10K: ORGANIC ELECTRIC SOLID-STATE DEVICES
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)
- C09K: MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE

## Abstract

Provided are organometallic compounds. Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

## Claims

### Claim 1

A compound comprising a ligand LA of Formula I
wherein:
one of Z1 and Z2 is C and the other is N;
each of K1 and K2 is independently a direct bond, S, or O;
ring A is a 5-membered or 6-membered carbocyclic or heterocyclic ring;
RA represents zero, mono, or up to the maximum allowed number of substitutions to its associated ring;
each of X1-X7 is independently N or CR;
at least one of R and RA has a structure of
wherein: each of X8-X15 is independently N or CR′, the particular one of X8-X15 that is bonded to one of X1-X7 or ring A of Formula I is C;
the maximum number of N atoms that can connect to each other within a ring is two;
each of the remaining R and RA is independently a hydrogen, Formula II, Formula III, or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof;
each of R′ and RB is independently a hydrogen, or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof;
the ligand LA is coordinated to a metal M by the indicated dash lines;
the ligand LA can be linked with other ligands to form a tridentate or tetradentate ligand;
M is Pd or Pt, and can be coordinated to additional ligands; and
any two adjacent R, R′, or RA can be joined or fused together to form a ring.

### Claim 2 (depends on 1)

The compound of claim 1, wherein each of the remaining R and RA is independently a hydrogen or a substituent selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, sulfanyl, and combinations thereof.

### Claim 3 (depends on 1)

The compound of claim 1, wherein X1-X7 are each CR, and X8-X15 are each independently C or CR′.

### Claim 4 (depends on 1)

The compound of claim 1, wherein one of X1-X15 is N, and the remainder of X1-X15 are each CR for X1-X7 and independently C or CR′ for X8-X15.

### Claim 5 (depends on 1)

The compound of claim 1, wherein two of X1-X15 is N, and the remainder of X1-X15 are each CR for X1-X7 and independently C or CR′ for X8-X15.

### Claim 6 (depends on 1)

The compound of claim 1, wherein one of X1-X7 is N, one of X8-X15 is N, and the remainder of X1-X15 are each CR for X1-X7 and independently C or CR′ for X8-X15.

### Claim 7 (depends on 1)

The compound of claim 1, wherein Z1 is N, and Z2 is C.

### Claim 8 (depends on 1)

The compound of claim 1, wherein Z1 is C, and Z2 is N.

### Claim 9 (depends on 1)

The compound of claim 1, wherein ring A is a 5-membered or 6-membered aromatic ring.

### Claim 10 (depends on 1)

The compound of claim 1, wherein the compound comprises a ligand LA of

### Claim 11 (depends on 1)

The compound of claim 1, wherein the compound has a structure of
wherein:
each of X1-X6 is independently N or CR;
at least one of R and RA has a structure of
wherein: each of X8-X15 is independently N or CR′, the particular one of X8-X15 that is bonded to one of X1-X6 or ring A of Formula VI is C;
rings C and D are each independently a 5-membered or 6-membered carbocyclic or heterocyclic ring;
each of K2, K3 or K4 is independently a direct bond, S, or O, with at least two of them being direct bonds;
Z3, Z4, Z5, and Z6 are each independently C or N;
L, L1, and L2 are each independently selected from the group consisting of a direct bond, being absent, O, S, CR″R′″ SiR″R′″, BR″, and NR″, wherein at least one of L1 and L2 is present;
RC and RD each independently represent zero, mono, or up to the maximum allowed number of substitutions to its associated ring;
each of R″, R′″, RC, and RD is independently a hydrogen or a substituent selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, sulfanyl, and combinations thereof;
M is Pd or Pt; and
any two adjacent R, R′, R″, R′″, RA, RB, RC, or RD can be joined or fused together to form a ring where chemically feasible.

### Claim 12 (depends on 1)

The compound of claim 1, wherein the compound is selected from the group consisting of:
wherein:
each of X1-X6 is independently N or CR;
at least one R or RA has a structure of
wherein: each of X8-X15 is independently N or CR′, the particular one of X8-X15 that is bonded to one of X1-X7 or ring A of Formula I is C;
Rx and Ry are each independently selected from the group consisting of alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aryl, heteroaryl, and combinations thereof; and
RE for each occurrence is independently a hydrogen or a substituent selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, sulfanyl, and combinations thereof.

### Claim 13 (depends on 1)

The compound of claim 1, wherein the compound is selected from the group consisting of:

### Claim 14 (depends on 1)

The compound of claim 1, wherein the compound is selected from the group consisting of Compound (l)-I-(A′i)(Bj)(Bk) to Compound (l)-XIV-(A′i)(Bj)(Bk) each Compound having the formula of Pt(LA)(LB) with the following structure:
wherein LA has the structure shown above and is selected from the group consisting of I-(A′i)(Bj)(Bk) to XIV-(A′i)(Bj)(Bk), wherein i is an integer from 1 to 7 and k is an integer from 1 to 47, and when i=1 to 3, j is an integer from 1 to 41, and when i=4 to 7, j is an integer from 1 to 47;
wherein LB has the structure shown above and is selected from the group consisting of Ll;
wherein l is an integer from 1 to 230107;
wherein rings C and D are as defined above for Formula VI; or
the compound can be selected from the group consisting of Compound [I-(A′i)(Bj)(Bk)][I-(A′m)(Bn)(Bo)] to Compound [XIV-(A′i)(Bj)(Bk)][XIV-(A′m)(Bn)(Bo)], each Compound having the formula of Pt(LA)(LC) with the following structure:
wherein LA is as defined above;
wherein LC has the structure shown above and is selected from the group consisting of I-(A′m)(Bn)(Bo) to XIV-(A′m)(Bn)(Bo);
wherein Ll for each occurrence independently has the structure defined in the table below: wherein each squiggly line in each structure is independently for linking to the relevant part of LA:
Ll
Structure of Ll
Ar1, Ar2, Ar3, R1, R2
for each Ll, wherein
thus defined ligands Ll to L9900
wherein Ar1 = Ap, and
l = 330(p − 1) + q,
each has a structure of
R1 = Rq, and
wherein p is an integer from 1 to 30, and q is an integer from 1 to 330,
for each Ll, wherein
thus defined ligands L9901 to
wherein Ar1= Ap and
l = 330(p − 1) + q + 9900,
L19800 each has a structure of
R1 = Rq, and
wherein p is an integer from 1 to 30, and q is an integer from 1 to 330,
for each Ll, wherein
thus defined ligands Ll9801 to
wherein Ar1 = Ap and
l = 330(p − 1) + q + 19800,
L29700 each has a structure of
R1 = Rq, and
wherein p is an integer from 1 to 30, and q is an integer from 1 to 330,
for each Ll, wherein
thus defined ligands L29701 to
wherein Ar1 = Ap and
l = 330(p − 1) + q + 29700,
L39600 each has a structure of
R1 = Rq, and
wherein p is an integer from 1 to 30, and q is an integer from 1 to 330,
for each Ll, wherein
thus defined ligands L39601 to
wherein Ar1 = Ap and
l = 330(p − 1) + q + 39600,
L49500 each has a structure of
R1 = Rq, and
wherein p is an integer from 1 to 30, and q is an integer from 1 to 330,
for each Ll, wherein
thus defined ligands L49501 to
wherein Ar1 = Ap and
l = 330(p − 1) + q + 49500,
L59400 each has a structure of
R1 = Rq, and
wherein p is an integer from 1 to 30, and q is an integer from 1 to 330,
for each Ll, wherein
thus defined ligands L59401 to
wherein Ar1 = Ap and
l = 330(p − 1) + q + 59400,
L69300 each has a structure of
R1 = Rq, and
wherein p is an integer from 1 to 30, and q is an integer from 1 to 330,
for each Ll, wherein
thus defined ligands L69301 to
wherein Ar1 = Ap and
l = 330(p − 1) + q + 69300,
L79200 each has a structure of
R1 = Rq, and
wherein p is an integer from 1 to 30, and q is an integer from 1 to 330,
for each Ll, wherein
thus defined ligands L79201 to
wherein R1 = Rq, and
l = q + 79200, wherein q is an
L79530 each has a structure of
integer from 1 to 330,
for each Ll, wherein
thus defined ligands L79531 to
wherein R1 = Rq, and
1 = q + 79530, wherein q is an
L79860 each has a structure of
integer from 1 to 330,
for each Ll, wherein
thus defined ligands L79861 to
wherein R1 = Rq, and
l = q + 79860, wherein q is an
L80190 each has a structure of
integer from 1 to 330,
for each Ll, wherein
thus defined ligands L80191 to
wherein R1 = Rq, and
l = q + 80190, wherein q is an
L80520 each has a structure of
integer from 1 to 330,
for each Ll, wherein
thus defined ligands L80521 to
wherein Ar1 = Ap and
l = 330(p − 1) + q + 80520,
L81510 each has a structure of
R1 = Rq, and
wherein p is an integer from 1 to 30, and q is an integer from 1 to 330,
for each Ll, wherein
thus defined ligands L81511 to
wherein R1 = Rq, and
l = q + 81510, wherein q is an
L82500 each has a structure of
integer from 1 to 330,
for each Ll, wherein
thus defined ligands L82501 to
wherein R1 = Rq, and
l = q + 82500, wherein q is an
L82830 each has a structure of
integer from 1 to 330,
for each Ll, wherein
thus defined ligands L82831 to
wherein R1 = Rq, and
l = q + 82830, wherein q is an
L83160 each has a structure of
integer from 1 to 330,
for each Ll, wherein
thus defined ligands L83161 to
wherein Ar1 = Ap and
l = 330(p − 1) + q + 83160,
L84150 each has a structure of
R1 = Rq, and
wherein p is an integer from 1 to 30, and q is an integer from 1 to 330,
for each Ll, wherein
thus defined ligands L84151 to
wherein Ar1 =Ap and
l = 330(p − 1) + q + 84150,
L85140 each has a structure of
R1 = Rq, and
wherein p is an integer from 1 to 30, and q is an integer from 1 to 330,
for each Ll, wherein
thus defined ligands L85141 to
wherein R1 = Rq, and
l = q + 85140, wherein q is an
L85470 each has a structure of
integer from 1 to 330,
for each Ll, wherein
thus defined ligands L85471 to
wherein R1 = Rq, and
l = q + 85470, wherein q is an
L85800 each has a structure of
integer from 1 to 330,
for each Ll, wherein
thus defined ligands L85801 to
wherein Ar1 = Ap and
l = 330(p − 1) + q + 85800,
L86790 each has a structure of
R1 = Rq, and
wherein p is an integer from 1 to 30, and q is an integer from 1 to 330,
for each Ll, wherein
thus defined ligands L86791 to
wherein Ar1 = Ap and
l = 330(p − 1) + q + 8679,
L87780 each has a structure of
R1 = Rq, and
wherein p is an integer from 1 to 30, and q is an integer from 1 to 330,
for each Ll, wherein
thus defined ligands L87781 to
wherein R1 = Rq, and
l = q + 87780, wherein q is an
L88110 each has a structure of
integer from 1 to 330,
for each Ll, wherein
thus defined ligands L88111 to
wherein Ar2 = Ar, and
l = r + 88110, wherein r is an
L88140 each has a structure of
integer from 1 to 30,
wherein ligand L88141
has the structure
for each Ll, wherein
thus defined ligands L88142 to
wherein Ar2 = Ar and
l = 30(r − 1) + s + 88141,
L89041 each has a structure of
Ar3 = As, and
wherein r is an integer from 1 to 30, and s is an integer from 1 to 30,
for each Ll, wherein
thus defined ligands L89042 to
wherein Ar2 = Ar, and
l = r + 89041, wherein r is an
L89071 each has a structure of
integer from 1 to 30,
for each Ll, wherein
thus defined ligands L89072 to
wherein Ar2 = Ar and
l = 30(r − 1) + s + 89071,
L89971 each has a structure of
Ar = As, and
wherein r is an integer from 1 to 30, and s is an integer from 1 to 30,
for each Ll, wherein
thus defined ligands L89972 to
wherein Ar2 = Ar, and
l = r + 89971, wherein r is an
L90001 each has a structure of
integer from 1 to 30,
for each Ll, wherein
thus defined ligands L90002 to
wherein Ar2 = Ar, and
l = r + 90001, wherein r is an
L90031 each has a structure of
integer from 1 to 30,
for each Ll, wherein
thus defined ligands L90032 to
wherein Ar2 = Ar and
l = 30(r − 1) + s + 90031,
L90931 each has a structure of
Ar3 = As, and
wherein r is an integer from 1 to 30, and s is an integer from 1 to 30,
for each Ll, wherein
thus defined ligands L90932 to
wherein Ar2 = Ar and
l = 30(r + 1) + s + 90931,
L91831 each has a structure of
Ar3 = As, and
wherein r is an integer from 1 to 30, and s is an integer from 1 to 30,
for each Ll, wherein
thus defined ligands L91832 to
wherein Ar2 = Ar and
l = 30(r − 1) + s + 91831,
L92731 each has a structure of
Ar3 = As, and
wherein r is an integer from 1 to 30, and s is an integer from 1 to 30,
for each Ll, wherein
thus defined ligands L92732 to
wherein Ar2 = Ar, and
l = r + 92731, wherein r is an
L92761 each has a structure of
integer from 1 to 30,
for each Ll, wherein
thus defined ligands L92762 to
wherein Ar2 = Ar and
l = 30(r − 1) + s + 92761,
L93661 each has a structure of
Ar3 = As, and
wherein r is an integer from 1 to 30, and s is an integer from 1 to 30,
for each Ll, wherein
thus defined ligands L93662 to
wherein Ar2 = Ar, and
l = r + 93661, wherein r is an
L93691 each has a structure of
integer from 1 to 30,
for each Ll, wherein
thus defined ligands L93692 to
wherein Ar2 = Ar and
l = 30(r − 1) + s + 93691,
L94591 each has a structure of
Ar3 = As, and
wherein r is an integer from 1 to 30, and s is an integer from 1 to 30,
for each Ll, wherein
thus defined ligands L94592 to
wherein Ar2 = Ar and
l = 30(r − 1) + s + 94591,
L95491 each has a structure of
Ar3 = As, and
wherein r is an integer from 1 to 30, and s is an integer from 1 to 30,
ligand L95492 has the structure of
for each Ll, wherein
thus defined ligands L95493 to
wherein Ar2 = Ar, and
l = r + 95492, wherein r is an
L95522 each has a structure of
integer from 1 to 30,
for each Ll, wherein
thus defined ligands L95523 to
wherein Ar2 = Ar, and
l = r + 95522, wherein r is an
L95552 each has a structure of
integer from 1 to 30,
for each Ll, wherein
thus defined ligands L95553 to
wherein Ar2 = Ar, and
l = r + 95552, wherein r is an
L95582 each has a structure of
integer from 1 to 30,
for each Ll, wherein
thus defined ligands L95583 to
wherein Ar2 = Ar, and
l = r + 95582, wherein r is an
L95612 each has a structure of
integer from 1 to 30,
ligand L95613 has the structure of
for each Ll, wherein
thus defined ligands L95614 to
wherein Ar1 = Ar, and
l = r + 95613, wherein r is an
L95643 each has a structure of
integer from 1 to 30,
for each Ll, wherein
thus defined ligands L95644 to
wherein Ar2 = Ar and
l = 30(r − 1) + s + 95643,
L96543 each has a structure of
Ar3 = As, and
wherein r is an integer from 1 to 30, and s is an integer from 1 to 30,
for each Ll, wherein
thus defined ligands L96544 to
wherein Ar2 = Ar, and
l = r +30 96543, wherein r is an
L96573 each has a structure of
integer from 1 to 30,
for each Ll, wherein
thus defined ligands L96574 to
wherein Ar2 = Ar and
l = 30(r − 1) + s + 96573,
L97473 each has a structure of
Ar3 = As, and
wherein r is an integer from 1 to 30, and s is an integer from 1 to 30,
for each Ll, wherein
thus defined ligands L97474 to
wherein Ar2 = Ar, and
l = r + 97473, wherein r is an
L97503 each has a structure of
integer from 1 to 30,
for each Ll, wherein
thus defined ligands L97504 to
wherein Ar2 = Ar, and
l = r + 97503, wherein r is an
L97533 each has a structure of
integer from 1 to 30,
for each Ll, wherein
thus defined ligands L97534 to
wherein Ar2 = Ar and
l = 30(r − 1) + s + 97533,
L98433 each has a structure of
Ar3 = As, and
wherein r is an integer from 1 to 30, and s is an integer from 1 to 30,
for each Ll, wherein
thus defined ligands L98434 to
wherein Ar2 = Ar and
l = 30(r − 1) + s + 98433,
L99333 each has a structure of
Ar3= As, and
wherein r is an integer from 1 to 30, and s is an integer from 1 to 30,
for each Ll, wherein
thus defined ligands L99334 to
wherein Ar2 = Ar, and
l = r + 99333, wherein r is an
L99363 each has a structure of
integer from 1 to 30,
ligand L99364 has the structure of
for each Ll, wherein
thus defined ligands L99365 to
wherein Ar2 = Ar,
l = r + 99364, wherein r is an
L99394 each has a structure of
wherein r is an integer
integer from 1 to 30,
from 1 to 30, and
ligand L99395 has the structure of
for each Ll, wherein
thus defined ligands L99396 to
wherein Ar2 = Ar and
l = 100(r − 1) + q + 99395,
L102395 each has a structure of
R2 = Rq, and
wherein r is an integer from 1 to 30, and q is an integer from 1 to 100,
for each Ll, wherein
thus defined ligands L102396 to
wherein R2 = Rq, and
l = q + 102395, wherein q is an
L102495 each has a structure of
integer from 1 to 100,
for each Ll, wherein
thus defined ligands L102496 to
wherein Ar2 = Ar and
l = 100(r − 1) + q + 102495,
L105495 each has a structure of
R2 = Rq, and
wherein r is an integer from 1 to 30, and q is an integer from 1 to 100,
for each Ll, wherein
thus defined ligands L105496 to
wherein R2 = Rq, and
l = q + 105495, wherein q is an
L105595 each has a structure of
integer from 1 to 100,
for each Ll, wherein
thus defined ligands L105596 to
wherein Ar2 = Ar and
l = 100(r − 1) + q + 105595,
L108595 each has a structure of
R2 = Rq, and
wherein r is an integer from 1 to 30, and q is an integer from 1 to 100,
for each Ll, wherein
thus defined ligands L108596 to
wherein R2 = Rq, and
l = q + 108595, wherein q is an
L108695 each has a structure of
integer from 1 to 100,
for each Ll, wherein
thus defined ligands L108696 to
wherein Ar2 = Ar and
l = 100(r − 1) + q + 111695,
L111695 each has a structure of
R2 = Rq, and
wherein r is an integer from 1 to 30, and q is an integer from 1 to 100,
for each Ll, wherein
thus defined ligands L111696 to
wherein R2 = Rq, and
l = q + 111795, wherein q is an
L111795 each has a structure of
integer from 1 to 100,
for each Ll, wherein
thus defined ligands L111796 to
wherein Ar2 = Ar and
l = 100(r − 1) + q + 111795,
L114795 each has a structure of
R2 = Rq, and
wherein r is an integer from 1 to 30, and q is an integer from 1 to 100,
for each Ll, wherein
thus defined ligands L114796 to
wherein R2 = Rq, and
l = q + 114795, wherein q is an
L114895 each has a structure of
integer from 1 to 100,
for each Ll, wherein
thus defined ligands L114896 to
wherein Ar2 = Ar and
l = 100(r − 1) + q + 114895,
L117895 each has a structure of
R2 = Rq, and
wherein r is an integer from 1 to 30, and q is an integer from 1 to 100,
for each Ll, wherein
thus defined ligands L117896 to
wherein R2 = Rq, and
l = q + 117895, wherein q is an
L117995 each has a structure of
integer from 1 to 100,
for each Ll, wherein
thus defined ligands L117996 to
wherein Ar2 = Ar and
l = 100(r − 1) + q + 117995,
L120995 each has a structure of
R2 = Rq, and
wherein r is an integer from 1 to 30, and q is an integer from 1 to 100,
for each Ll, wherein
thus defined ligands L120996 to
wherein R2 = Rq, and
l = q + 120995, wherein q is an
L121095 each has a structure of
integer from 1 to 100,
for each Ll, wherein
thus defined ligands L121096 to
wherein Ar2 = Ar, and
l = r + 121095, wherein r is an
L121125 each has a structure of
integer from 1 to 30,
ligand L121126 has the structure of
for each Ll, wherein
thus defined ligands L121127 to
wherein Ar2 = Ar and
l = 30(r − 1) + s + 121126,
L122026 each has a structure of
Ar3 = As, and
wherein r is an integer from 1 to 30, and s is an integer from 1 to 30,
for each Ll, wherein
thus defined ligands L122027 to
wherein Ar2 = Ar, and
l = r + 122026, wherein r is an
L122056 each has a structure of
integer from 1 to 30,
for each Ll, wherein
thus defined ligands L122057 to
wherein Ar2 = Ar and
l = 30(r − 1) + s + 122056,
L122956 each has a structure of
Ar3 = As, and
wherein r is an integer from 1 to 30, and s is an integer from 1 to 30,
for each Ll, wherein
thus defined ligands L122957 to
wherein Ar2 = Ar, and
l = r + 122956, wherein r is an
L122986 each has a structure of
integer from 1 to 30,
for each Ll, wherein
thus defined ligands L122987 to
wherein Ar2 = Ar, and
l = r + 122986, wherein r is an
L123016 each has a structure of
integer from 1 to 30,
Ligand L123017 has a structure of
for each Ll, wherein
thus defined ligands L123018 to
wherein Ar2 = Ar and
l = 30(r − 1) + s + 123017,
L123917 each has a structure of
Ar3 = As, and
wherein r is an integer from 1 to 30, and s is an integer from 1 to 30,
for each Ll, wherein
thus defined ligands L123918 to
wherein Ar2 = Ar, and
l = r + 223917, wherein r is an
L123947 each has a structure of
integer from 1 to 30,
for each Ll, wherein
thus defined ligands L223948 to
wherein Ar2 = Ar and
l = 30(r − 1) + s + 223947,
L224847 each has a structure of
Ar3 = As, and
wherein r is an integer from 1 to 30, and s is an integer from 1 to 30,
for each Ll, wherein
thus defined ligands L224848 to
wherein Ar2 = Ar, and
l = r + 224847, wherein r is an
L224877 each has a structure of
integer from 1 to 30,
for each Ll, wherein
thus defined ligands L224878 to
wherein Ar2 = Ar and
l = 30(r − 1) + s + 224877,
L225777 each has a structure of
Ar3 = As, and
wherein r is an integer from 1 to 30, and s is an integer from 1 to 30,
for each Ll, wherein
thus defined ligands L225778 to
wherein Ar2 = Ar, and
l = r + 225777, wherein r is an
L225807 each has a structure of
integer from 1 to 30,
for each Ll, wherein
thus defined ligands L225808 to
wherein Ar2 = Ar and
l = 30(r − 1) + s + 225807,
L226707 each has a structure of
Ar3 = As, and
wherein r is an integer from 1 to 30, and s is an integer from 1 to 30,
for each Ll, wherein
thus defined ligands L226708 to
wherein Ar2 = Ar, and
l = r + 226707, wherein r is an
L226737 each has a structure of
integer from 1 to 30,
for each Ll, wherein
thus defined ligands L226738 to
wherein Ar2 = Ar and
l = 30(r − 1) + s + 226737,
L227637 each has a structure of
Ar3 = As, and
wherein r is an integer from 1 to 30, and s is an integer from 1 to 30,
for each Ll, wherein
thus defined ligands L227638 to
wherein Ar2 = Ar, and
l = r + 227637,
L227667 each has a structure of
wherein r is an integer from 1 to 30,
for each Ll, wherein
thus defined ligands L227668 to
wherein Ar2 = Ar and
l = 30(r − 1) + s + 227667,
L228567 each has a structure of
Ar3 = As, and
wherein r is an integer from 1 to 30, and s is an integer from 1 to 30,
for each Ll, wherein
thus defined ligands L228568 to
wherein Ar2 = Ar, and
l = r + 228567, wherein r is an
L228597 each has a structure of
integer from 1 to 30,
for each Ll, wherein
thus defined ligands L228598 to
wherein Ar2 = Ar, and
l = r + 228597, wherein r is an
L228627 each has a structure of
integer from 1 to 30,
for each Ll, wherein
thus defined ligands L228628 to
wherein Ar2 = Ar, and
l = r + 228627, wherein r is an
L228657 each has a structure of
integer from 1 to 30,
for each Ll, wherein
thus defined ligands L228658 to
wherein Ar2 = Ar, and
l = r + 228657, wherein r is an
L228687 each has a structure of
integer from 1 to 30,
for each Ll, wherein
thus defined ligands L228688 to
wherein Ar2 = Ar, and
l = r + 228787, wherein r is
L228717 each has a structure of
integer from 1 to 30,
for each Ll, wherein
thus defined ligands L228718 to
wherein Ar2 = Ar, and
l = r + 228717, wherein r is an
L228747 each has a structure of
integer from 1 to 30,
for each Ll, wherein
thus defined ligands L228748 to
wherein Ar2 = Ar, and
l = r + 228747, wherein r is an
L228777 each has a structure of
integer from 1 to 30,
ligand L228778 has a structure of
ligand L228779 has a structure of
ligand L228780 has a structure of
ligand L228781 has a structure of
ligand L228782 has a structure of
ligand L228783 has a structure of
for each Ll, wherein
thus defined ligands L228784 to
wherein R1 = Rq, and
l = q + 228783, wherein q is an
L229114 each has a structure of
integer from 1 to 330,
for each Ll, wherein
thus defined ligands L229115 to
wherein R1 = Rq, and
l = q + 229114, wherein q is an
L229445 each has a structure of
integer from 1 to 330,
for each Ll, wherein
thus defined ligands L229446 to
wherein R1 = Rq, and
l = q + 229445, wherein q is an
L229776 each has a structure of
integer from 1 to 330,
for each Ll, wherein
thus defined ligands L229777 to
wherein R1 = Rq,
l = q + 229776, wherein q is an
L230107 each has a structure of
integer from 1 to 330,
wherein A1 to A30 have the following structures:
and
wherein R1 to R330 have the following structures:
and
wherein LA and LC independently have the structures defined in the table below:
Structure
i, j, k, m, n, o
where LA is I-(A′i)(Bj)(Bk) and LC is I-(A′m)(Bn)(Bo) having the structure
wherein i is an integer from 1 to 7 and k is an integer from 1 to 47, and when i = 1 to 3, j is an integer from 1 to 41, and when i = 4 to 7, j is an integer from 1 to 47; wherein m is an integer from 1 to 7 and o is an integer from 1 to 47, and when m = 1 to 3, n is an integer from 1 to 41, and when m = 4 to 7, n is an integer from 1 to 47; wherein LA and LC are independently selected from the group consisting of I- (A′1)(B1)(B1) to I-(A′3)(B41)(B47), and I-(A′4)(B1)(B1) to I-(A′7)(B47)(B47),
where LA is II- (A′i)(Bj)(Bk) and LC is II (A′m)(Bn)(Bo) having the structure
wherein i is an integer from 1 to 7 and k is an integer from 1 to 47; when i = 1 to 3, j is an integer from 1 to 41 and when i = 4 to 7, j is an integer from 1 to 47, and when m = 1 to 3, n is an integer from to 4, and when m = 4 to 7, n is an integer from 1 to 47; wherein LA and LC are independently selected from the group consisting of II-(A′1)(B1)(B1) to II- (A′3)(B41)(B47), and II-(A′4)(B1)(B1) to II-(A′7)(B47)(B47),
where LA is III- (A′i)(Bj)(Bk) and LC is III- (A′m)(Bn)(Bo), having the structure
wherein i is an integer from 1 to 7 and k is an integer from 1 to 47; when i = 1 to 3, j is an integer from 1 to 41 and when i = 4 to 7, j is an integer from 1 to 47, and when m = 1 to 3, n is an integer from to 4, and when m = 4 to 7, n is an integer from 1 to 47; wherein LA and LC are independently selected from the group consisting of III-(A′1)(B1)(B1) to III- (A′3)(B41)(B47), and III-(A′4)(B1)(B1) to III-(A′7)(B47)(B47),
where LA is IV- (A′i)(Bj)(Bk) and LC is IV- (A′m)(Bn)(Bo), having the structure
wherein i is an integer from 1 to 7 and k is an integer from 1 to 47; when i = 1 to 3, j is an integer from 1 to 41 and when i = 4 to 7, j is an integer from 1 to 47, and when m = 1 to 3, n is an integer from to 4, and when m = 4 to 7, n is an integer from 1 to 47; wherein LA and LC are independently selected from the group consisting of IV-(A′1)(B1)(B1) to IV- (A′3)(B41)(B47), and IV-(A′4)(B1)(B1) to IV-(A′7)(B47)(B47),
where LA is V- (A′i)(Bj)(Bk) and LC is V- (A′m)(Bn)(Bo), having the structure
wherein i is an integer from 1 to 7 and k is an integer from 1 to 47; when i or m = 1 to 3, j is an integer from 1 to 41 and when i = 4 to 7, j is an integer from 1 to 47, and when m = 1 to 3, n is an integer from to 4, and when m = 4 to 7, n is an integer from 1 to 47; wherein LA and LC are independently selected from the group consisting of V-(A′1)(B1)(B1) to V- (A′3)(B41)(B47), and V-(A′4)(B1)(B1) to V-(A′7)(B47)(B47),
where LA is VI- (A′i)(Bj)(Bk) and LC is VI- (A′m)(Bn)(Bo), having the structure
wherein i is an integer from 1 to 7 and k is an integer from 1 to 47; when i = 1 to 3, j is an integer from 1 to 41 and when i = 4 to 7, j is an integer from 1 to 47, and when m = 1 to 3, n is an integer from to 4, and when m = 4 to 7, n is an integer from 1 to 47; wherein LA and LC are independently selected from the group consisting of VI-(A′1)(B1)(B1) to VI- (A′3)(B41)(B47), and VI-(A′4)(B1)(B1) to VI-(A′7)(B47)(B47),
where LA is VII-(A′i)(Bj) and LC is VII-(A′m)(Bn), having the structure
wherein i is an integer from 1 to 7; when i = 1 to 3, j is an integer from 1 to 41 and when i = 4 to 7, j is an integer from 1 to 47, and when m = 1 to 3, n is an integer from to 4, and when m = 4 to 7, n is an integer from 1 to 47; wherein LA and LC are independently selected from the group consisting of VII-(A′1)(B1)(B1) to VII- (A′3)(B41)(B47), and VII-(A′4)(B1)(B1) to VII-(A′7)(B47)(B47),
where LA is VIII-(A′i)(Bj) and LC is VIII-(A′m)(Bn), having the structure
wherein i is an integer from 1 to 7; when i = 1 to 3, j is an integer from 1 to 41 and when i or m = 4 to 7, j is an integer from 1 to 47, and when m = 1 to 3, n is an integer from to 4, and when m = 4 to 7, n is an integer from 1 to 47; wherein LA and LC are independently selected from the group consisting of VII-(A′1)(B1)(B1) to VII- (A′3)(B41)(B47), and VII-(A′4)(B1)(B1) to VII-(A′7)(B47)(B47),
where LA is IX-(A′i)(Bj) and LC is IX-(A′m)(Bn), having the structure
wherein i is an integer from 1 to 7; when i = 1 to 3, j is an integer from 1 to 41 and when i = 4 to 7, j is an integer from 1 to 47, and when m = 1 to 3, n is an integer from to 4, and when m = 4 to 7, n is an integer from 1 to 47; wherein LA and LC are independently selected from the group consisting of IX-(A′1)(B1)(B1) to IX- (A′3)(B41)(B47), and IX-(A′4)(B1)(B1) to IX-(A′7)(B47)(B47),
where LA is X-(A′i)(Bj) and LC is X-(A′m)(Bn), having the structure
wherein i is an integer from 1 to 7; when i = 1 to 3, j is an integer from 1 to 41 and when i = 4 to 7, j is an integer from 1 to 47, and when m = 1 to 3, n is an integer from to 4, and when m = 4 to 7, n is an integer from 1 to 47; wherein LA and LC are independently selected from the group consisting of X-(A′1)(B1)(B1) to X- (A′3)(B41)(B47), and X-(A′4)(B1)(B1) to X-(A′7)(B47)(B47),
where LA is XI-(A′i)(Bj) and LC is XI-(A′m)(Bn), having the structure
wherein i is an integer from 1 to 7; when i = 1 to 3, j is an integer from 1 to 41 and when i = 4 to 7, j is an integer from 1 to 47, and when m = 1 to 3, n is an integer from to 4, and when m = 4 to 7, n is an integer from 1 to 47; wherein LA and LC are independently selected from the group consisting of XI-(A′1)(B1)(B1) to XI- (A′3)(B41)(B47), and XI-(A4)(B1)(B1) to XI-(A′7)(B47)(B47),
where LA is XII-(A′i)(Bj) and LC is XII-(A′m)(Bn), having the structure
wherein i is an integer from 1 to 7; when i = 1 to 3, j is an integer from 1 to 41 and when i = 4 to 7, j is an integer from 1 to 47, and when m = 1 to 3, n is an integer from to 4, and when m = 4 to 7, n is an integer from 1 to 47; wherein LA and LC are independently selected from the group consisting of XII-(A′1)(B1)(B1) to XII- (A′3)(B41)(B47), and XII-(A′4)(B1)(B1) to XI-(A′7)(B47)(B47),
where LA is XIII- (A′i)(Bj)(Bk) and LC is XIII-(A′m)(Bn)(Bo), having the structure
wherein i is an integer from 1 to 7 and k is an integer from 1 to 47; when i = 1 to 3, j is an integer from 1 to 41 and when i = 4 to 7, j is an integer from 1 to 47, and when m = 1 to 3, n is an integer from to 4, and when m = 4 to 7, n is an integer from 1 to 47; wherein LA and LC are independently selected from the group consisting of XIII-(A′1)(B1)(B1) to XIII- (A′3)(B41)(B47), and XIII-(A′4)(B1)(B1) to XI-(A′7)(B47)(B47),
where LA is XIV- (A′)(Bj)(Bk) and LC is XIV-(A′m)(Bn)(Bo), having the structure
wherein i is an integer from 1 to 7 and k is an integer from 1 to 47; when i = 1 to 3, j is an integer from 1 to 41 and when i = 4 to 7, j is an integer from 1 to 47, and when m = 1 to 3, n is an integer from to 4, and when m = 4 to 7, n is an integer from 1 to 47; wherein LA and LC are independently selected from the group consisting of XII-(A′1)(B1)(B1) to XII- (A′3)(B41)(B47), and XII-(A′4)(B1)(B1) to XI-(A′7)(B47)(B47),
wherein A′1 to A′7 have the following structures:
wherein B1 to B47 have the following structures:

### Claim 15 (depends on 1)

The compound of claim 1, wherein the compound is selected from the group consisting of

### Claim 16

An organic light emitting device (OLED) comprising:
an anode;
a cathode; and
an organic layer disposed between the anode and the cathode,
wherein the organic layer comprises a compound comprising a ligand LA of Formula I
wherein:
one of Z1 and Z2 is C and the other is N;
each of K1 and K2 is independently a direct bond, S, or O;
ring A is a 5-membered or 6-membered carbocyclic or heterocyclic ring;
RA represents zero, mono, or up to the maximum allowed number of substitutions to its associated ring;
each of X1-X7 is independently N or CR;
at least one of R and RA has a structure of
wherein: each of X8-X15 is independently N or CR′, the particular one of X8-X15 that is bonded to one of X1-X7 or ring A of Formula I is C;
the maximum number of N atoms that can connect to each other within a ring is two;
each of the remaining R and RA is independently a hydrogen, Formula II, Formula III, or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof;
each of R′ and RB is independently a hydrogen, or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof;
the ligand LA is coordinated to a metal M by the indicated dash lines;
the ligand LA can be linked with other ligands to form a tridentate or tetradentate ligand;
M is Pd or Pt, and can be coordinated to additional ligands; and
any two adjacent R, R′, or RA can be joined or fused together to form a ring.

### Claim 17 (depends on 16)

The OLED of claim 16, wherein the organic layer further comprises a host, wherein host comprises at least one chemical moiety selected from the group consisting of triphenylene, carbazole, indolocarbazole, dibenzothiphene, dibenzofuran, dibenzoselenophene, 5,9-dioxa-13b-boranaphtho[3,2,1-de]anthracene, aza-triphenylene, aza-carbazole, aza-indolocarbazole, aza-dibenzothiophene, aza-dibenzofuran, aza-dibenzoselenophene, and aza-(5,9-dioxa-13b-boranaphtho[3,2,1-de]anthracene).

### Claim 18 (depends on 17)

The OLED of claim 17, wherein the host is selected from the group consisting of:
and combinations thereof.

### Claim 19

A consumer product comprising an organic light-emitting device (OLED) comprising:
an anode;
a cathode; and
an organic layer disposed between the anode and the cathode,
wherein the organic layer comprises a compound comprising a ligand LA of Formula I
wherein:
one of Z1 and Z2 is C and the other is N;
each of K1 and K2 is independently a direct bond, S, or O;
ring A is a 5-membered or 6-membered carbocyclic or heterocyclic ring;
RA represents zero, mono, or up to the maximum allowed number of substitutions to its associated ring;
each of X1-X7 is independently N or CR;
at least one of R and RA has a structure of
wherein: each of X8-X15 is independently N or CR′, the particular one of X8-X15 that is bonded to one of X1-X7 or ring A of Formula I is C;
the maximum number of N atoms that can connect to each other within a ring is two;
each of the remaining R and RA is independently a hydrogen, Formula II, Formula III, or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof;
each of R′ and RB is independently a hydrogen, or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof;
the ligand LA is coordinated to a metal M by the indicated dash lines;
the ligand LA can be linked with other ligands to form a tridentate or tetradentate ligand;
M is Pd or Pt, and can be coordinated to additional ligands; and
any two adjacent R, R′, or RA can be joined or fused together to form a ring.

### Claim 20 (depends on 1)

A formulation comprising a compound according to claim 1.
